These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28542441)

  • 21. Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations.
    Kendall EA; Malhotra S; Cook-Scalise S; Denkinger CM; Dowdy DW
    BMC Infect Dis; 2019 Sep; 19(1):794. PubMed ID: 31500572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
    Cox H; Hughes J; Daniels J; Azevedo V; McDermid C; Poolman M; Boulle A; Goemaere E; van Cutsem G
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):441-8. PubMed ID: 24670700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An integrated community TB-HIV adherence model provides an alternative to DOT for tuberculosis patients in Cape Town.
    Kaplan R; Caldwell J; Hermans S; Adriaanse S; Mtwisha L; Bekker LG; Jennings K; Wood R
    Int J Tuberc Lung Dis; 2016 Sep; 20(9):1185-91. PubMed ID: 27510244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes.
    Monge S; Diez M; Pulido F; Iribarren JA; Campins AA; Arazo P; Montero M; Miro JM; Moreno S; Del Amo J;
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):700-8. PubMed ID: 24903942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa.
    Cox H; Ramma L; Wilkinson L; Azevedo V; Sinanovic E
    Trop Med Int Health; 2015 Oct; 20(10):1337-45. PubMed ID: 25975868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.
    TB:HIV Study writing Group
    AIDS; 2017 Jan; 31(3):375-384. PubMed ID: 28081036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes and implementation challenges of using daily treatment regimens with an innovative adherence support tool among HIV-infected tuberculosis patients in Karnataka, India: a mixed-methods study.
    Thekkur P; Kumar AN; Chinnakali P; Selvaraju S; Bairy R; Singh AR; Nirgude A; Selvaraj K; Venugopal V; Shastri S
    Glob Health Action; 2019; 12(1):1568826. PubMed ID: 30712507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TB-HIV co-infection among pregnant women in Karnataka, South India: A case series.
    Suresh S; Sharath BN; Anita S; Lalitha R; Prasad TJ; Rewari BB
    J Infect Public Health; 2016; 9(4):465-70. PubMed ID: 26711476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study.
    Nagu TJ; Aboud S; Matee MI; Maeurer MJ; Fawzi WW; Mugusi F
    J Antimicrob Chemother; 2017 Mar; 72(3):876-881. PubMed ID: 27999054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
    Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W
    J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five years retrospective cohort analysis of treatment outcomes of TB-HIV patients at a PEPFAR/DOTS Centre in South Eastern Nigeria.
    Babatunde OI; Christiandolus EO; Bismarck EC; Emmanuel OI; Chike AC; Gabriel EI
    Afr Health Sci; 2016 Sep; 16(3):655-662. PubMed ID: 27917196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study.
    Manosuthi W; Tantanathip P; Chimsuntorn S; Eampokarap B; Thongyen S; Nilkamhang S; Sungkanuparph S
    Int J Infect Dis; 2010 Nov; 14(11):e1013-7. PubMed ID: 20880733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review.
    Arentz M; Pavlinac P; Kimerling ME; Horne DJ; Falzon D; Schünemann HJ; Royce S; Dheda K; Walson JL;
    PLoS One; 2012; 7(11):e47370. PubMed ID: 23144818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss to follow-up among adolescents with tuberculosis in Gaborone, Botswana.
    Enane LA; Lowenthal ED; Arscott-Mills T; Matlhare M; Smallcomb LS; Kgwaadira B; Coffin SE; Steenhoff AP
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1320-1325. PubMed ID: 27725042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
    Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis treatment survival of HIV positive TB patients on directly observed treatment short-course in Southern Ethiopia: a retrospective cohort study.
    Shaweno D; Worku A
    BMC Res Notes; 2012 Dec; 5():682. PubMed ID: 23234241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a pro-active strategy for managing tuberculosis-HIV co-infection in a UK tertiary care setting.
    Wake RM; Poulikakos P; Groth J; Harrison TS; Macallan DC
    Int J STD AIDS; 2013 Apr; 24(4):263-8. PubMed ID: 23635810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia.
    Walls G; Bulifon S; Breysse S; Daneth T; Bonnet M; Hurtado N; Molfino L
    Glob Health Action; 2015; 8():25964. PubMed ID: 25623609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.